Hepatitis B virus core protein promotes the expression of neuraminidase 1 to facilitate hepatocarcinogenesis


Neuraminidase 1 (NEU1) has been reported to be associated with hepatocellular carcinoma (HCC). However, the function and associated molecular mechanisms of NEU1 in hepatitis B virus (HBV)-related HCC have not been well investigated. In the present study, the expression of NEU1 mediated by HBV and HBV core protein (HBc) was measured in hepatoma cells. The expression of NEU1 protein was detected via immunohistochemical analysis in HBV-associated HCC tissues. The role of NEU1 in the activation of signaling pathways and epithelial-mesenchymal transition (EMT) and the proliferation and migration of hepatoma cells mediated by HBc was assessed. We found that NEU1 was upregulated in HBV-positive hepatoma cells and HBV-related HCC tissues. HBV promoted NEU1 expression at the mRNA and protein level via HBc in hepatoma cells. Mechanistically, HBc was able to enhance the activity of the NEU1 promoter through NF-κB binding sites. In addition, through the increase in NEU1 expression, HBc contributed to activation of downstream signaling pathways and EMT in hepatoma cells. Moreover, NEU1 facilitated the proliferation and migration of hepatoma cells mediated by HBc. Taken together, our findings provide novel insight into the molecular mechanism underlying the oncogenesis mediated by HBc and demonstrate that NEU1 plays a vital role in HBc-mediated functional abnormality in HCC. Thus, NEU1 may serve as a potential therapeutic target in HBV-associated HCC.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: The role of HBc in NEU1 expression in HBV-related hepatoma cells.
Fig. 2: The effect of the NF-κB pathway in activation of the NEU1 promoter mediated by HBc in hepatoma cells.
Fig. 3: The role of NEU1 inhibition via shRNA in intracellular signaling pathways and EMT in HBc-positive hepatoma cells.
Fig. 4: The effect of NEU1 inhibition by OP on intracellular signaling pathways and EMT in HBc-positive hepatoma cells.
Fig. 5: The role of NEU1 in the proliferation of hepatoma cells induced by HBc.
Fig. 6: The effect of NEU1 on the migration of hepatoma cells mediated by HBc.


  1. 1.

    Xu W, Yu J, Wong VW. Mechanism and prediction of HCC development in HBV infection. Best Pract Res Clin Gastroenterol. 2017;31:291–8.

    Article  Google Scholar 

  2. 2.

    Wang M, Xi D, Ning Q. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int. 2017;11:171–80.

    Article  Google Scholar 

  3. 3.

    Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:S84–101.

    Article  CAS  Google Scholar 

  4. 4.

    Diab A, Foca A, Zoulim F, Durantel D, Andrisani O. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: implications for the development of HBc-targeting antivirals. Antiviral Res. 2018;149:211–20.

    Article  CAS  Google Scholar 

  5. 5.

    Du J, Liang X, Liu Y, Qu Z, Gao L, Han L, et al. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Cell Death Differ. 2009;16:219–29.

    Article  CAS  Google Scholar 

  6. 6.

    Liu W, Lin YT, Yan XL, Ding YL, Wu YL, Chen WN, et al. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. FASEB J. 2015;29:1113–23.

    Article  CAS  Google Scholar 

  7. 7.

    Gai X, Zhao P, Pan Y, Shan H, Yue X, Du J, et al. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner. Int J Biochem Cell Biol. 2013;45:1174–85.

    Article  CAS  Google Scholar 

  8. 8.

    Liu W, Guo TF, Jing ZT, Yang Z, Liu L, Yang YP, et al. Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src/PI3K/Akt pathway. FASEB J. 2018;32:3033–46.

    Article  CAS  Google Scholar 

  9. 9.

    Xie Q, Fan F, Wei W, Liu Y, Xu Z, Zhai L, et al. Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells. Sci Rep. 2017;7:41089.

    Article  CAS  Google Scholar 

  10. 10.

    Du J, Bai F, Zhao P, Li X, Gao L, Ma C, et al. Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p/DLC-1 axis. Biochim Biophys Acta Mol Cell Res. 2018;1865:1–11.

    Article  CAS  Google Scholar 

  11. 11.

    Haxho F, Neufeld RJ, Szewczuk MR. Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis. Oncotarget. 2016;7:40860–81.

    Article  Google Scholar 

  12. 12.

    Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN. Sialidase activity in human pathologies. Eur J Pharmacol. 2019;842:345–50.

    Article  CAS  Google Scholar 

  13. 13.

    Hou G, Liu G, Yang Y, Li Y, Yuan S, Zhao L, et al. Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma. Oncotarget. 2016;7:64957–66.

    Article  Google Scholar 

  14. 14.

    Wang W, Peng JX, Yang JQ, Yang LY. Identification of gene expression profiling in hepatocellular carcinoma using cDNA microarrays. Dig Dis Sci. 2009;54:2729–35.

    Article  CAS  Google Scholar 

  15. 15.

    Amaddeo G, Cao Q, Ladeiro Y, Imbeaud S, Nault JC, Jaoui D, et al. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas. Gut. 2015;64:820–9.

    Article  CAS  Google Scholar 

  16. 16.

    Kong F, You H, Zhao J, Liu W, Hu L, Luo W, et al. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-alpha related apoptosis inducing ligand) TRAIL in hepatoma cells. Virol J. 2015;12:192.

    Article  CAS  Google Scholar 

  17. 17.

    You H, Kong F, Zhou K, Wei X, Hu L, Hu W, et al. HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells. J Cell Physiol. 2018;233:7279–91.

    Article  CAS  Google Scholar 

  18. 18.

    Kong F, Hu W, Zhou K, Wei X, Kou Y, You H, et al. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-kappaB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells. J Exp Clin Cancer Res. 2016;35:172.

    Article  CAS  Google Scholar 

  19. 19.

    Tang R, Kong F, Hu L, You H, Zhang P, Du W, et al. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells. Virol J. 2012;9:163.

    Article  CAS  Google Scholar 

  20. 20.

    Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70:10202–12.

    Article  CAS  Google Scholar 

  21. 21.

    Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, et al. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology. 2012;142:957–66.

    Article  CAS  Google Scholar 

  22. 22.

    Kong FY, Zhu T, Li N, Cai YF, Zhou K, Wei X, et al. Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma. Sci Rep. 2017;7:44017.

    Article  Google Scholar 

  23. 23.

    Kong FY, Wei X, Zhou K, Hu W, Kou YB, You HJ, et al. Bioinformatics analysis reveals distinct molecular characteristics of hepatitis B-related hepatocellular carcinomas from very early to advanced barcelona clinic liver cancer stages. PLoS ONE. 2016;11:e0158286.

    Article  CAS  Google Scholar 

  24. 24.

    Wang H, Shi J, Luo Y, Liao Q, Niu Y, Zhang F, et al. LIM and SH3 protein 1 induces TGFbeta-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression. Clin Cancer Res. 2014;20:5835–47.

    Article  CAS  Google Scholar 

  25. 25.

    Chen GY, Brown NK, Wu W, Khedri Z, Yu H, Chen X, et al. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. Elife. 2014;3:e04066.

    Article  CAS  Google Scholar 

  26. 26.

    Chen Z, Li YX, Fu HJ, Ren YL, Zou L, Shen SZ, et al. Hepatitis B virus core antigen stimulates IL-6 expression via p38, ERK and NF-kappaB pathways in hepatocytes. Cell Physiol Biochem. 2017;41:91–100.

    Article  CAS  Google Scholar 

  27. 27.

    Mulero MC, Huxford T, Ghosh G. NF-kappaB, IkappaB, and IKK: integral components of immune system signaling. Adv Exp Med Biol. 2019;1172:207–26.

    Article  CAS  Google Scholar 

  28. 28.

    Duca L, Blanchevoye C, Cantarelli B, Ghoneim C, Dedieu S, Delacoux F, et al. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J Biol Chem. 2007;282:12484–91.

    Article  CAS  Google Scholar 

  29. 29.

    Natori Y, Nasui M, Edo K, Sato S, Sakurai T, Kizaki T, et al. NEU1 sialidase controls gene expression and secretion of IL-6 and MCP-1 through NF-kappaB pathway in 3T3-L1 adipocytes. J Biochem. 2017;162:137–43.

    PubMed  CAS  Google Scholar 

  30. 30.

    O’Shea LK, Abdulkhalek S, Allison S, Neufeld RJ, Szewczuk MR. Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu(R)) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance. Onco Targets Ther. 2014;7:117–34.

    PubMed  PubMed Central  Google Scholar 

  31. 31.

    Mak LY, Wong DK, Seto WK, Lai CL, Yuen MF. Hepatitis B core protein as a therapeutic target. Expert Opin Ther Targets. 2017;21:1153–59.

    Article  CAS  Google Scholar 

  32. 32.

    Uemura T, Shiozaki K, Yamaguchi K, Miyazaki S, Satomi S, Kato K, et al. Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. Oncogene. 2009;28:1218–29.

    Article  CAS  Google Scholar 

  33. 33.

    Xiang A, Ren F, Lei X, Zhang J, Guo R, Lu Z, et al. The hepatitis B virus (HBV) core protein enhances the transcription activation of CRE via the CRE/CREB/CBP pathway. Antiviral Res. 2015;120:7–15.

    Article  CAS  Google Scholar 

  34. 34.

    Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci. 2005;118:873–87.

    Article  CAS  Google Scholar 

  35. 35.

    Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, et al. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling. Cancer Res. 2011;71:4846–56.

    Article  CAS  Google Scholar 

  36. 36.

    Ren LR, Zhang LP, Huang SY, Zhu YF, Li WJ, Fang SY, et al. Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer. Mol Cell Biochem. 2016;411:213–9.

    Article  CAS  Google Scholar 

Download references


The work was supported by a project funded by Jiangsu Health and Family Planning Commission (Z2018017), National Natural Science Foundation of China (81702053), Natural Science Foundation of Jiangsu Province (BK20170263), the China Postdoctoral Science Foundation funded Project (2016M591925), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Scientific Research Foundation for the Talents of Xuzhou Medical University (D2016011), and the Jiangsu Planned Projects for Postdoctoral Research Funds (1601190C).

Author information



Corresponding authors

Correspondence to Hongjuan You or Renxian Tang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kong, F., Li, N., Tu, T. et al. Hepatitis B virus core protein promotes the expression of neuraminidase 1 to facilitate hepatocarcinogenesis. Lab Invest (2020). https://doi.org/10.1038/s41374-020-0465-9

Download citation


Quick links